Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Grant supports IBBR's development of multispecific antibody as therapeutic for HIV

Sep. 6, 2017

GlaxoSmithKline, ViiV identify new HIV allosteric integrase inhibitors

Sep. 5, 2017

ViiV Healthcare divulges new HIV maturation inhibitors

Aug. 24, 2017

GlaxoSmithKline identifies novel ingenol derivatives

Aug. 16, 2017

EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate

Aug. 11, 2017

FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV

Aug. 11, 2017

Mologen announces results from extension phase of TEACH study of lefitolimod in HIV

Aug. 10, 2017

GlaxoSmithKline patents HIV maturation inhibitors

Aug. 9, 2017

Mylan receives PEPFAR tentative approval for TLD fixed-dose combination regimen

Aug. 8, 2017

Janssen reports results of APPROACH study of Ad26.Mos.HIV HIV-1 vaccine regimens

Aug. 8, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...